| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/1997 | US5624952 Vasoconstrictors |
| 04/29/1997 | US5624951 4-hydroxy coumarin derivatives with antibacterial activity |
| 04/29/1997 | US5624950 Useful in treatment of analgesia, inflammation, asthma, allergies, central nervous system disorders, cardiovascular disorders, immune system disorders, antispasmodic agents, antiemetic agents |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624946 Use of leflunomide to control and reverse chronic allograft rejection |
| 04/29/1997 | US5624945 Use of riluzole for the treatment of neuro-aids |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624943 Pyridine compounds which are useful as leukotriene-B4 -antagonists |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 04/29/1997 | US5624939 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 04/29/1997 | US5624938 Use of chloroquine to treat multiple sclerosis |
| 04/29/1997 | US5624935 Antidiabetic agents, hypoglycemic agents or antilipemic agents |
| 04/29/1997 | US5624934 Protease inhibitors |
| 04/29/1997 | US5624932 Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction |
| 04/29/1997 | US5624931 Pyrazole derivatives |
| 04/29/1997 | US5624930 Carbocyclic nucleoside analogs useful as immunosuppressants |
| 04/29/1997 | US5624927 N-[4-(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines and n-[4(heteroaryl)-1-piperazinyl)alkyl]-1,2,3,4-tetrahydroisoquinolines, related compounds and their therapeutic utility |
| 04/29/1997 | US5624925 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 04/29/1997 | US5624924 Quinobenzothiazine antineoplastic agents |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624919 Trans platinum (IV) complexes |
| 04/29/1997 | US5624917 Method of inhibiting squalene synthetase |
| 04/29/1997 | US5624915 Hyaluronic acid-urea pharmaceutical compositions and uses |
| 04/29/1997 | US5624914 Everninomycins, cyclodextran derivative, nonionic surfactant |
| 04/29/1997 | US5624911 Antiinflammatory agents or analgesics |
| 04/29/1997 | US5624910 Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse |
| 04/29/1997 | US5624909 Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (e-selectin) and LECAM-1 (l-selectin) |
| 04/29/1997 | US5624908 Antineoplastic compositions |
| 04/29/1997 | US5624903 Phosphoinositol-glycan-peptide with insulin-like action |
| 04/29/1997 | US5624897 Parasiticides, nematosides of cyclic peptide lactones for veterinary medicine |
| 04/29/1997 | US5624893 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
| 04/29/1997 | US5624842 Strain of Streptomyces for the production of tricyclo compounds |
| 04/29/1997 | US5624830 Selectivity killing mammalian host cells in vitro |
| 04/29/1997 | US5624807 Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms |
| 04/29/1997 | US5624683 Bunazosin |
| 04/29/1997 | US5624682 Pharmaceutical formulations based on a ketoprofen solution in soft capsules, and processes for their preparation |
| 04/29/1997 | US5624677 Controlled release of drugs delivered by sublingual or buccal administration |
| 04/29/1997 | US5624675 Genital lubricants containing zinc salts to reduce risk of HIV infection |
| 04/29/1997 | US5624670 Use of interleukin-8 for inducing cervical ripening |
| 04/29/1997 | US5624668 Iron dextran formulations |
| 04/29/1997 | US5624411 Intravascular stent and method |
| 04/29/1997 | CA2089207C Amphoteric tricyclic compound |
| 04/29/1997 | CA2065501C Preparation process of ginkgolide b from ginkgolide c |
| 04/29/1997 | CA2021546C [r-(r*r*)]1-2-(4-fluorophenyl).beta.-.delta.-dihydroxy-5- (1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]-1h-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 04/29/1997 | CA2003190C Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid |
| 04/28/1997 | CA2188908A1 Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/28/1997 | CA2187911A1 Prolongation of organ transplantation using rapamycin loaded donor splenocytes |
| 04/28/1997 | CA2186192A1 Topical composition containing specific flavanones |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014966A1 Method of activating a novel ligand regulatory pathway |
| 04/24/1997 | WO1997014808A2 Herpesvirus vectors and their uses |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014802A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 04/24/1997 | WO1997014800A1 Novel saliva binding protein |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014782A1 Live vaccines against gram-negative pathogens, expressing heterologous o-antigens |
| 04/24/1997 | WO1997014716A1 Cyclopeptide derivatives |
| 04/24/1997 | WO1997014715A1 Receptor-selective somatostatin analogs |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014712A2 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them |
| 04/24/1997 | WO1997014695A1 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO[3,4':4,5]FURO(3,2-b)PYRIDINE-6,8[7H]-DIONE DERIVATIVES FOR USE IN CONTROLLING ENDOPARASITES AND A METHOD OF PRODUCING SAID DERIVATIVES |
| 04/24/1997 | WO1997014691A1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors |
| 04/24/1997 | WO1997014690A1 5-(acetamidomethyl)-3-aryldihydrofuran-2-one and tetrahydrofuran-2-one derivatives with antibiotic activity |
| 04/24/1997 | WO1997014686A1 Pharmaceutically active quinazoline compounds |
| 04/24/1997 | WO1997014684A1 Amino substituted pyrimidines and triazines |
| 04/24/1997 | WO1997014683A2 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 04/24/1997 | WO1997014679A2 Method of detecting cyclooxygenase-2 |
| 04/24/1997 | WO1997014671A1 Cyclopentyl tachykinin receptor antagonists |
| 04/24/1997 | WO1997014670A1 Lignans, a process for their production and pharmaceutical compositions and uses thereof |
| 04/24/1997 | WO1997014442A1 Hormone immunomodulated induction of mucosal immune responses |
| 04/24/1997 | WO1997014438A1 Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist |
| 04/24/1997 | WO1997014436A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 04/24/1997 | WO1997014434A1 Influenza vaccine |
| 04/24/1997 | WO1997014433A1 Chicken interleukin-15 and uses thereof |
| 04/24/1997 | WO1997014429A1 Stable pharmaceutical forms of administration containing parathormone |
| 04/24/1997 | WO1997014427A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014422A1 Multiple vitamin supplement composition |
| 04/24/1997 | WO1997014421A1 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum |
| 04/24/1997 | WO1997014420A1 Treating fibrosis in skeletal muscle tissue |
| 04/24/1997 | WO1997014419A1 Transdermal delivery of alpha adrenoceptor blocking agents |
| 04/24/1997 | WO1997014418A1 16-substituted-6-aza-steroid 5-alpha-reductase inhibitors |
| 04/24/1997 | WO1997014417A1 Fibrinogen receptor antagonists |
| 04/24/1997 | WO1997014416A1 Conjugates useful in the treatment of benign prostatic hyperplasia |
| 04/24/1997 | WO1997014415A1 Analgesic immediate and controlled release pharmaceutical composition |
| 04/24/1997 | WO1997014414A1 Use of nitroflavonoids for the treatment of anxiety |
| 04/24/1997 | WO1997014411A1 Percutaneous tulobuterol preparation and process for producing the same |
| 04/24/1997 | WO1997014410A1 Lipid alcohols as new immunosuppressive and antiviral drugs |
| 04/24/1997 | WO1997014409A1 Thrombolytic agents and methods of treatment for thrombosis |
| 04/24/1997 | WO1997014407A1 Insoluble drug delivery |
| 04/24/1997 | WO1997014307A1 Method for treating ischemic tissue |
| 04/24/1997 | WO1997014306A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1997011680A3 Hormone replacement therapy method and hormone dispenser |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | WO1997007784A3 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 04/24/1997 | WO1997005267A3 Mucosal delivery of polynucleotides |
| 04/24/1997 | WO1996040055A3 Biological agent compositions |